MannKind Corp
MNKD
$3.67
Share price
2.23%
Change (1 day)
-21.91%
Change (1 year)
Categories
P/S ratio for MannKind Corp (MNKD)
P/S ratio as of December 2023 (TTM): 5.60
According to MannKind Corp's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 5.60377. At the end of 2023 the company had a P/S ratio of 6.28.
P/S ratio history for MannKind Corp from 2008 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 6.28 | -54.85% |
| 2022 | 13.9 | -4.48% |
| 2021 | 14.6 | 28.53% |
| 2020 | 11.3 | 161.27% |
| 2019 | 4.33 | -39.1% |
| 2018 | 7.12 | -69.69% |
| 2017 | 23.5 | 1247.23% |
| 2016 | 1.74 | |
| 2015 | N/A | |
| 2014 | N/A | |
| 2013 | N/A | -100% |
| 2012 | > 1000 | 187.47% |
| 2011 | > 1000 | -40.71% |
| 2010 | > 1000 | |
| 2009 | N/A | -100% |
| 2008 | > 1000 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | 2.36 | -57.91% | 🇺🇸 USA |
 Novo Nordisk NVO | 14.4 | 157.65% | 🇩🇰 Denmark |
 Eli Lilly LLY | 17.4 | 210.72% | 🇺🇸 USA |
 Merck MRK | 4.44 | -20.80% | 🇺🇸 USA |
 Halozyme Therapeutics HALO | 6.79 | 21.23% | 🇺🇸 USA |
 Nektar Therapeutics
NKTR | 1.10 | -80.43% | 🇺🇸 USA |